Metopirone

(Metyrapone)

The active ingredient in Metopirone is metyrapone.

The mechanism of action for Metyrapone works by blocking an enzyme in the adrenal cortex that is involved in cortisol production. This leads to a drop in cortisol levels and a rise in certain cortisol precursors, such as 11-desoxycortisol. Measuring these changes through blood tests helps assess pituitary and adrenal gland function during diagnostic testing.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide before using Metopirone. However, the following is a synopsis of the general guidelines for the use of Metopirone:

• Metopirone is taken by oral administration.
• It may be used as a single dose or as part of a multiple-dose test, depending on the type of diagnostic test ordered.
• Dosing is carefully calculated based on the dose of Metopirone required for the test, age, and body weight.
• Blood samples are collected at specific times to measure cortisol-related hormones.
• Because Metopirone can significantly affect cortisol levels, it should only be used exactly as directed and under medical supervision. Do not take extra doses or repeat testing without medical advice.

Some mild or common side effects of Metopirone seen in clinical trials as compared to placebo include:

• Drowsy feeling.
• Dizziness.
• Nausea.
• Stomach pain.
• Headache.

Some individuals may experience serious side effects while using Metopirone. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Signs of adrenal insufficiency such as weakness, fatigue, or hypotension.
• Low blood pressure with lightheadedness or fainting.
• Severe nausea or vomiting.
• Allergic reaction including skin rash, hives, or swelling.

These are not all of the possible side effects of Metopirone. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Metopirone, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including if you have:

• Adrenal insufficiency or adrenocortical insufficiency.
• Leukopenia, anemia, and/or thrombocytopenia.
• Heart disease or unstable blood pressure.
• Liver disease.
• A history of allergic reaction to metyrapone.
• Conditions requiring corticosteroid therapy.
• Because Metopirone lowers cortisol, patients may require close monitoring for signs of hypotension or adrenal crisis during testing.

Metopirone should not be used in patients with:

• Known hypersensitivity or adverse reactions to metyrapone or any formulation component.
• Severe adrenal insufficiency unless closely supervised.
• Your healthcare provider will determine whether Metopirone is appropriate based on your medical condition and diagnostic needs.

Metopirone works relatively quickly. Changes in cortisol-related hormone levels can be detected within hours after dosing. Peak plasma concentrations and measurable hormone changes typically occur during the test window defined by the healthcare professional. The medication is not intended for long-term use. The response to Metopirone does not occur immediately. Following oral administration, peak steroid excretion occurs during the subsequent 24-hour period. The plasma elimination half-life of metyrapone is about 2 hours after oral administration.

When Metopirone is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

Phenytoin, which may alter metyrapone metabolism and affect test results.

• Cyproheptadine, which may interfere with hormonal responses.
• Estrogen-containing medicines, which may affect cortisol measurements.
• Corticosteroids such as hydrocortisone, which can alter test accuracy.
• Acetaminophen, which may affect laboratory hormone measurements.
• Titanium dioxide.
• Ethyl vanillin.
• Drug interactions can interfere with the results of the metyrapone test, so full disclosure of medications is essential.

Metopirone is available in capsule dosage form for oral administration. Dosing depends on the specific diagnostic protocol and patient characteristics.

It should be stored at room temperature, away from the reach of children or pets.

Metopirone is a registered trademark and has been manufactured by different pharmaceutical companies depending on region and availability.

Yes. Metyrapone is the generic name for Metopirone.

Metopirone is usually taken for a short diagnostic period only. Once the test is complete, no further doses are taken unless directed by a healthcare provider. Do not repeat or stop testing without medical advice.

Talk to your doctor if you are already pregnant or if you have any plans to become pregnant. Metopirone should only be used during for pregnant women if clearly needed, and the potential benefits outweigh the risks. Your healthcare provider will determine what is best for you. Animal reproductive studies have not been conducted with this drug.

Talk to your doctor if you are already breastfeeding or if you have any plans to breastfeed. It is not known whether metyrapone passes into breast milk. Your healthcare provider will advise whether breastfeeding should be paused or if an alternative approach is recommended. Metyrapone and its active metabolite, metyrapol, are present in human milk; there are no available data on effects on breastfed infant or on milk production.